Moving Forward with Decentralized Clinical Trials (DCTs) - November 9, 14, & 16, 2023

Don’t miss this opportunity to learn the important considerations for implementing decentralized clinical trials and get the key take-aways from the recently issued FDA Draft Guidance on Decentralized Clinical Trials.

戻る Agenda

Part 3: Conducting the Study

Session Chair(s)

Amy Bohn

Director, DCT Operations, DCT Strategy & Implementation

Bayer, United States

Session 13: Welcome and Recap of Part 2
Session 14: Participant Recruitment and Retention Strategies
Session 15: Remote Components: Managing Risks and Issue Resolution
Session 16: Inspections and Audits
Session 17: Establishing Best Practices for DCT Operations
Session 18: Exercise
Questions and Answers, Wrap-up

Moving Forward with Decentralized Clinical Trials (DCTs) - November 9, 14, & 16, 2023

Part 3: Conducting the Study

Session Chair(s)

Amy Bohn

最新情報や機会を逃さないで